CAMBRIDGE, MA, USA – Knome, Inc. and Personal Genomics, s.r.l., Verona, Italy, announced an exclusive sales alliance for Knome’s knoSYS™ platform in Italy and a scientific partnership for continued development of the platform’s tools, content, and applications. Knome offers the fully integrated knoSYS platform for the management and interpretation of human genome sequence data. The […]
CAMBRIDGE, MA –– GnuBIO, a privately-held life sciences company that has developed a droplet-based DNA sequencing technology, today announced that it was acquired by Bio-Rad Laboratories, Inc. With this acquisition, Bio-Rad will expand its Digital Biology Center and establish a research and development site in Cambridge, Massachusetts. GnuBIO has developed a DNA sequencing solution that […]
St. Louis, MO — MOgene LC, an Illumina CSPro™ certified service provider, announced today that they have added Illumina NextSeq 500 to their list of services. Illumina NextSeq 500 performs whole-genome, exome, and transcriptome sequencing and is flexible, offering tunable read length and multiple output configurations which offers researchers another option for high quality results […]
BILLERICA, Mass and SAN DIEGO —— RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetics, today announced the availability of its ThunderBolts™ Cancer Panel, a comprehensive next-generation DNA sequencing (NGS)solution that enables researchers to profile a wide range of tumor samples in fewer than two days for as low as $100 […]
SAN DIEGO — Knowledge of driver mutations is essential to research and development in the pharmaceutical industry for the identification of novel populations and discovery of new cancer drug targets. Gene over-expression is one of the prevalent cancer driver events, but cancer transcriptome expression data generated in labs around the world are difficult to collect, […]
SAN DIEGO, California, and HILDEN, Germany — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced two important new product launches which address workflow challenges in next-generation sequencing (NGS) applications. QIAGEN will present these and several other innovative solutions for NGS applications at the American Association for Cancer Research (AACR) Annual Meeting from April […]
BILLERICA, Mass. –– RainDance Technologies, Inc., an innovative genomics tools company making molecular testing of complex diseases more standardized and readily available, today announced that it has closed a $16.5 million Series E financing round extension. New investors include GE Ventures and Northgate Capital; all existing financial investors also participated in this round of financing. […]
ST LOUIS, MO – Appistry, Inc., a leading provider of high-performance computing and analytics solutions for next-generation medicine, today released the latest commercial version of the Broad Institute’s Genome Analysis Toolkit (GATK). GATK 3 provides new functionality and best practices to tackle modern challenges in next-generation sequencing (NGS) data analysis. “The Broad Institute has described […]
Denville, NJ — Diagenode, Inc., a leading global provider of shearing technologies and complete solutions for epigenetics research, recently launched its Megaruptor DNA fragmentation instrument, part of its shearing technologies product line. A number of applications for massively parallel sequencing, also known as Next-Generation Sequencing, require libraries of long DNA segments, but few methods have […]
Hawthorne, CA and Rutherford, NJ — Cancer Genetics, Inc. (Nasdaq: CGIX) and BioDiscovery, Inc. have announced expansion of the Nexus Copy Number Discovery platform in CGI research to uncover novel biomarkers which are predictive of cancer outcomes. “Cancer Genetics has been able to leverage the Nexus Copy Number platform’s unique ability to quickly digest large […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
